Trial Profile
Vortioxetine for the Treatment of Major Depression and Neuropsychiatric Co-morbidities After Traumatic Brain Injury (TBI)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Depression
- Focus Therapeutic Use
- 01 Sep 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 29 Jul 2016 New trial record